Search

everythinglearnresearchcommunity

for

Search:↓

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

PCOS is a complex disorder needing lifestyle changes, support, and treatment, with new herbal treatments showing promise.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Understanding EGFR roles could lead to new hair loss treatments.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

Microneedling may help treat some autoimmune skin conditions, but more research is needed.

The mats help heal wounds and support bone growth while controlling infections.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Photobiomodulation may help reduce pain and inflammation in knee osteoarthritis, but its long-term benefits are unclear.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

taVNS reduces vitiligo symptoms in mice.

New therapies are being developed that target integrin pathways to treat various diseases.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

3D spheroid culture makes stem cells better at reducing inflammation.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

The TRPV3 gene variant may cause the long-haired suri alpaca coat.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.